The Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) Market is expected to register a CAGR of nearly 4% over the forecast period 2021-2027. PF-ILD is a collective term used for indications that share a common progressive phenotype. The phenotype is characterized by worsening respiratory symptoms, decreased lung function, limited response to immunomodulatory therapy, decreased quality of life, […]
